Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial.
Lindemann CH, Burst V, Völker LA, Brähler S, Simic D, Becker I, Hellmich M, Kurscheid C, Scholten N, Krauspe R, Leibel K, Stock S, Brinkkoetter PT. Lindemann CH, et al. Among authors: volker la. Trials. 2024 Mar 11;25(1):177. doi: 10.1186/s13063-024-08026-8. Trials. 2024. PMID: 38468319 Free PMC article.
Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment.
Ney S, Gertz RJ, Pennig L, Nies RJ, Holtick U, Völker LA, Wunderlich G, Seuthe K, Hohmann C, Metze C, Nähle CP, von Stein J, Brüwer M, Ten Freyhaus H, Pfister R. Ney S, et al. Among authors: volker la. J Clin Med. 2024 Jan 4;13(1):284. doi: 10.3390/jcm13010284. J Clin Med. 2024. PMID: 38202291 Free PMC article.
Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis.
Diefenhardt P, Braumann M, Schömig T, Trinsch B, Sierra Gonzalez C, Becker-Gotot J, Völker LA, Ester L, Mandel AM, Hawiger D, Abdallah AT, Schermer B, Göbel H, Brinkkötter P, Kurts C, Benzing T, Brähler S. Diefenhardt P, et al. Among authors: volker la. J Am Soc Nephrol. 2023 Aug 1;34(8):1366-1380. doi: 10.1681/ASN.0000000000000159. Epub 2023 Jun 26. J Am Soc Nephrol. 2023. PMID: 37367205
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Völker LA, Kaufeld J, Balduin G, Merkel L, Kühne L, Eichenauer DA, Osterholt T, Hägele H, Kann M, Grundmann F, Kolbrink B, Schulte K, Gäckler A, Kribben A, Boss K, Potthoff SA, Rump LC, Schmidt T, Mühlfeld AS, Schulmann K, Hermann M, Gaedeke J, Sauerland K, Bramstedt J, Hinkel UP, Miesbach W, Bauer F, Westhoff TH, Bruck H, Buxhofer-Ausch V, Müller TJ, Wendt R, Harth A, Schreiber A, Seelow E, Tölle M, Gohlisch C, Bieringer M, Geuther G, Jabs WJ, Fischereder M, von Bergwelt-Baildon A, Schönermarck U, Knoebl P, Menne J, Brinkkoetter PT; German TTP-Study Group. Völker LA, et al. J Thromb Haemost. 2023 Mar;21(3):559-572. doi: 10.1016/j.jtha.2022.11.010. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696206 Free article.
Speciation and Structures in Pt Surface Sites Stabilized by N-Heterocyclic Carbene Ligands Revealed by Dynamic Nuclear Polarization Enhanced Indirectly Detected 195Pt NMR Spectroscopic Signatures and Fingerprint Analysis.
Wang Z, Völker LA, Robinson TC, Kaeffer N, Menzildjian G, Jabbour R, Venkatesh A, Gajan D, Rossini AJ, Copéret C, Lesage A. Wang Z, et al. Among authors: volker la. J Am Chem Soc. 2022 Nov 30;144(47):21530-21543. doi: 10.1021/jacs.2c08300. Epub 2022 Nov 16. J Am Chem Soc. 2022. PMID: 36383737
73 results